PD-0325901 Completed Phase 2 Trials for Neurofibromatosis Type 1 and Growing or Symptomatic, Inoperable PN Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs